BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24913135)

  • 1. Extracellular matrix and cytochrome P450 gene expression can distinguish steatohepatitis from steatosis in mice.
    Hennig EE; Mikula M; Goryca K; Paziewska A; Ledwon J; Nesteruk M; Woszczynski M; Walewska-Zielecka B; Pysniak K; Ostrowski J
    J Cell Mol Med; 2014 Sep; 18(9):1762-72. PubMed ID: 24913135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The FLS (fatty liver Shionogi) mouse reveals local expressions of lipocalin-2, CXCL1 and CXCL9 in the liver with non-alcoholic steatohepatitis.
    Semba T; Nishimura M; Nishimura S; Ohara O; Ishige T; Ohno S; Nonaka K; Sogawa K; Satoh M; Sawai S; Matsushita K; Imazeki F; Yokosuka O; Nomura F
    BMC Gastroenterol; 2013 Jul; 13():120. PubMed ID: 23875831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Series of microRNA in the Chromosome 14q32.2 Maternally Imprinted Region Related to Progression of Non-Alcoholic Fatty Liver Disease in a Mouse Model.
    Okamoto K; Koda M; Okamoto T; Onoyama T; Miyoshi K; Kishina M; Kato J; Tokunaga S; Sugihara TA; Hara Y; Hino K; Murawaki Y
    PLoS One; 2016; 11(5):e0154676. PubMed ID: 27135827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of cytochrome P450 in nonalcoholic fatty liver induced by high-fat diet: a gene expression profile analysis].
    Liu Y; Cheng F; Luo YX; Hu P; Ren H; Peng ML
    Zhonghua Gan Zang Bing Za Zhi; 2017 Apr; 25(4):285-290. PubMed ID: 28494548
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatic Alanine Differentiates Nonalcoholic Steatohepatitis From Simple Steatosis in Humans and Mice: A Proton MR Spectroscopy Study With Long Echo Time.
    Kim TH; Jun HY; Kim KJ; Lee YH; Lee MS; Choi KH; Yun KJ; Jeong YY; Jun CH; Cho EY; Yoon KH
    J Magn Reson Imaging; 2017 Nov; 46(5):1298-1310. PubMed ID: 28225569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of lumican and fatty acid binding protein-1: new insights into the histologic spectrum of nonalcoholic fatty liver disease.
    Charlton M; Viker K; Krishnan A; Sanderson S; Veldt B; Kaalsbeek AJ; Kendrick M; Thompson G; Que F; Swain J; Sarr M
    Hepatology; 2009 Apr; 49(4):1375-84. PubMed ID: 19330863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nrf2 deletion causes "benign" simple steatosis to develop into nonalcoholic steatohepatitis in mice fed a high-fat diet.
    Wang C; Cui Y; Li C; Zhang Y; Xu S; Li X; Li H; Zhang X
    Lipids Health Dis; 2013 Nov; 12():165. PubMed ID: 24188280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Key hepatic signatures of human and mouse nonalcoholic steatohepatitis: A transcriptome-proteome data meta-analysis.
    Pyo JJ; Choi Y
    Front Endocrinol (Lausanne); 2022; 13():934847. PubMed ID: 36267572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Gene Expression Patterns Between Mouse Models of Nonalcoholic Fatty Liver Disease and Liver Tissues From Patients.
    Teufel A; Itzel T; Erhart W; Brosch M; Wang XY; Kim YO; von Schönfels W; Herrmann A; Brückner S; Stickel F; Dufour JF; Chavakis T; Hellerbrand C; Spang R; Maass T; Becker T; Schreiber S; Schafmayer C; Schuppan D; Hampe J
    Gastroenterology; 2016 Sep; 151(3):513-525.e0. PubMed ID: 27318147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonalcoholic steatohepatitis versus steatosis: adipose tissue insulin resistance and dysfunctional response to fat ingestion predict liver injury and altered glucose and lipoprotein metabolism.
    Musso G; Cassader M; De Michieli F; Rosina F; Orlandi F; Gambino R
    Hepatology; 2012 Sep; 56(3):933-42. PubMed ID: 22684858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma phospholipids and fatty acid composition differ between liver biopsy-proven nonalcoholic fatty liver disease and healthy subjects.
    Ma DW; Arendt BM; Hillyer LM; Fung SK; McGilvray I; Guindi M; Allard JP
    Nutr Diabetes; 2016 Jul; 6(7):e220. PubMed ID: 27428872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals.
    Suppli MP; Rigbolt KTG; Veidal SS; Heebøll S; Eriksen PL; Demant M; Bagger JI; Nielsen JC; Oró D; Thrane SW; Lund A; Strandberg C; Kønig MJ; Vilsbøll T; Vrang N; Thomsen KL; Grønbæk H; Jelsing J; Hansen HH; Knop FK
    Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G462-G472. PubMed ID: 30653341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of genes encoding mitochondrial proteins can distinguish nonalcoholic steatosis from steatohepatitis.
    Bragoszewski P; Habior A; Walewska-Zielecka B; Ostrowski J
    Acta Biochim Pol; 2007; 54(2):341-8. PubMed ID: 17502923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular interplay between Δ5/Δ6 desaturases and long-chain fatty acids in the pathogenesis of non-alcoholic steatohepatitis.
    López-Vicario C; González-Périz A; Rius B; Morán-Salvador E; García-Alonso V; Lozano JJ; Bataller R; Cofán M; Kang JX; Arroyo V; Clària J; Titos E
    Gut; 2014 Feb; 63(2):344-55. PubMed ID: 23492103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiological analysis of nonalcoholic fatty liver disease by evaluation of fatty liver changes and blood flow using xenon computed tomography: can early-stage nonalcoholic steatohepatitis be distinguished from simple steatosis?
    Shigefuku R; Takahashi H; Kobayashi M; Ikeda H; Matsunaga K; Okuse C; Matsumoto N; Maeyama S; Sase S; Suzuki M; Itoh F
    J Gastroenterol; 2012 Nov; 47(11):1238-47. PubMed ID: 22576023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo cytochrome P450 activity alterations in diabetic nonalcoholic steatohepatitis mice.
    Li H; Clarke JD; Dzierlenga AL; Bear J; Goedken MJ; Cherrington NJ
    J Biochem Mol Toxicol; 2017 Feb; 31(2):. PubMed ID: 27712037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adipose tissue dysfunction signals progression of hepatic steatosis towards nonalcoholic steatohepatitis in C57BL/6 mice.
    Duval C; Thissen U; Keshtkar S; Accart B; Stienstra R; Boekschoten MV; Roskams T; Kersten S; Müller M
    Diabetes; 2010 Dec; 59(12):3181-91. PubMed ID: 20858684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic gene expression in patients with obesity-related non-alcoholic steatohepatitis.
    Younossi ZM; Gorreta F; Ong JP; Schlauch K; Del Giacco L; Elariny H; Van Meter A; Younoszai A; Goodman Z; Baranova A; Christensen A; Grant G; Chandhoke V
    Liver Int; 2005 Aug; 25(4):760-71. PubMed ID: 15998427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and activity of the cytochrome P450 2E1 in patients with nonalcoholic steatosis and steatohepatitis.
    Chtioui H; Semela D; Ledermann M; Zimmermann A; Dufour JF
    Liver Int; 2007 Aug; 27(6):764-71. PubMed ID: 17617119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of microsomal triglyceride transfer protein in nonalcoholic steatohepatitis in novel spontaneous mouse model.
    Shindo N; Fujisawa T; Sugimoto K; Nojima K; Oze-Fukai A; Yoshikawa Y; Wang X; Yasuda O; Ikegami H; Rakugi H
    J Hepatol; 2010 Jun; 52(6):903-12. PubMed ID: 20392512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.